Addus HomeCare (NASDAQ:ADUS) Rating Lowered to “Buy” at Wall Street Zen

Addus HomeCare (NASDAQ:ADUS) was downgraded by Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued on Sunday.

Several other analysts have also recently commented on the stock. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the stock a “buy” rating in a report on Wednesday, January 7th. TD Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Royal Bank Of Canada increased their price target on Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th. Finally, Barclays upped their target price on Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 4th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and an average price target of $135.44.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $110.37 on Friday. The business has a fifty day moving average of $112.29 and a 200 day moving average of $113.16. Addus HomeCare has a 1 year low of $88.96 and a 1 year high of $134.64. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a market capitalization of $2.04 billion, a price-to-earnings ratio of 23.63, a price-to-earnings-growth ratio of 1.32 and a beta of 0.92.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.53 by $0.03. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.The business had revenue of $362.30 million for the quarter, compared to analyst estimates of $354.48 million. During the same period in the prior year, the company earned $1.30 earnings per share. The company’s revenue was up 25.0% on a year-over-year basis. As a group, research analysts expect that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, EVP Darby Anderson sold 20,000 shares of the stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $109.00, for a total transaction of $2,180,000.00. Following the transaction, the executive vice president owned 44,144 shares in the company, valued at approximately $4,811,696. This represents a 31.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders sold a total of 20,316 shares of company stock worth $2,215,998 in the last quarter. Corporate insiders own 4.50% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Institutional investors have recently added to or reduced their stakes in the stock. Tributary Capital Management LLC increased its holdings in Addus HomeCare by 114.1% in the 3rd quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock worth $46,974,000 after acquiring an additional 212,192 shares in the last quarter. Capital Research Global Investors increased its stake in shares of Addus HomeCare by 9.0% during the third quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock worth $141,772,000 after purchasing an additional 99,262 shares in the last quarter. Leeward Investments LLC MA acquired a new position in shares of Addus HomeCare during the 2nd quarter worth about $9,152,000. 8 Knots Management LLC acquired a new position in shares of Addus HomeCare during the 3rd quarter worth about $6,075,000. Finally, TimesSquare Capital Management LLC lifted its stake in Addus HomeCare by 13.9% in the 2nd quarter. TimesSquare Capital Management LLC now owns 394,047 shares of the company’s stock valued at $45,390,000 after buying an additional 48,207 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.